pharmaphorum
JUNE 8, 2022
Owners of an iPhone or Apple Watch have a new health feature, an app called Medications, that will help them manage and track their use of medicines. The new tool works as a component of Apple’s Health app and will let users add drugs or other health products like vitamins and supplements to a personal list – either by scanning a label or finding the product in a directory – and create custom schedules for them.
Outsourcing Pharma
JUNE 8, 2022
An expert from Rockwell Automation explains how integrating flexibility, using advanced technology, can help pharma manufacturing operations weather a storm.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
pharmaphorum
JUNE 8, 2022
Abbott is already a big player in the wearable glucose-monitoring sector, and has started working on a new device that will measure both glucose and ketones, potentially serving as a warning system for a life-threatening complication of diabetes known as ketoacidosis. The system – which already has a breakthrough device designation from the FDA – will take the form of a small patch-like device similar to Abbott’s FreeStyle Libre 3 device (pictured above), and a prototype version is already
NF2 BioSolutions
JUNE 8, 2022
Pete hiked the Inca Trail to raise funds for NF2 BioSolutions UK! He has already raised £7600 as of the start of June and Pete’s fundraising page is open for donations until the 30th June 2022. Here is how his adventure panned out… Day 1 of my Inca Trail adventure was a nice breaking in day, with a steady but challenging trek. We started off at 8am (after waking at 3am for a 2.5 hour coach journey to start point) and finished off at 5.00pm with a beer and a view.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
pharmaphorum
JUNE 8, 2022
Sleep and its importance to health is becoming a greater focus of research. With more research being published, the public is becoming more aware of sleep’s functions and there are a number of apps and devices that now allow users to gauge the quality of their rest. Ben Hargreaves uncovers why this interest in sleep could be more than a fad and might actually play a key role in research and clinical studies in the future.
Pharma Mirror
JUNE 8, 2022
Shanghai/Amsterdam: CPHI & P-MEC China opens its online international partnering platform as pharmaceutical and biopharmaceutical industries in the country report strong underlying conditions and see increases in all categories of the most recent CPHI Pharma Index [1] – an annual score of each country’s pharma industry strength – with its overall score rising by 7.2%, the largest increase of any nation.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
Pharma Mirror
JUNE 8, 2022
SYDNEY, Novotech, the leading Asia Pacific biotech specialist CRO which has recently expanded its services to the US, is sponsoring the Endpoints ASCO 22 “Accelerating clinical development in China and the US” Register here [link] JUNE 711:00am – 11:45am ET (1:00 – 1:45 local time)Novotech Booth at ASCO #14115 The virtual session will cover the latest on the clinical trial landscape and infrastructure in China and includes Novotech’s DCT partner, Obvio Health, on DC
pharmaphorum
JUNE 8, 2022
June 7, 2022, Washington DC – Fishawack Health (FH) announces the acquisition of leading healthcare consulting and advisory firm Avalere Health (Avalere) from Inovalon , which acquired the consultancy in 2015. . FH is a leading global commercialization partner for biopharmaceutical, medical technology, and wellness companies. A healthcare consulting firm for more than 20 years, Avalere partners with leading life sciences companies, health plans, providers, and investors to bring innovative, d
Outsourcing Pharma
JUNE 8, 2022
The June 20 Medical Heroes Appreciation 5k Run and Walk, scheduled during the DIA Global Annual Meeting in Chicago, salutes contributions of trial volunteers.
pharmaphorum
JUNE 8, 2022
Driving a Holistic Approach to Assurance of Product Sterility through Aseptic Manufacturing following QRM Principles. Sponsored by: Dec Group, Rapid Micro Biosystems and STERIS. [link]. Conference Chairman: James Drinkwater, Head of Aseptic Processing Special Interest Group PHSS and Head of GMP Compliance, F Ziel GMBH. SME Media Group proudly presents the 2nd Annual Aseptic Processing Conference, this year taking place in London, on the 19 and 20 September 2022.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Outsourcing Pharma
JUNE 8, 2022
Offering 13 topic tracks to choose from, the DIA Global Annual Meeting (scheduled June 19-23) lets attendees chose the path that fits their unique interests.
Med Ed 101
JUNE 8, 2022
Long-Acting Injectable (LAI) Antipsychotics Antipsychotic agents are often discontinued without provider consultation, leading to poorer outcomes and quality of life. Luckily, newer formulations are continually being developed to help address barriers to care and promote tolerance. Long-acting injectable (LAI) antipsychotics are becoming more widely used in psychiatric care today.
Pharma Times
JUNE 8, 2022
The companies have partnered for a second time to support sector-wide efforts to eliminate hepatitis C virus in drug and alcohol services
pharmaphorum
JUNE 8, 2022
Roche has secured its first regulatory approval for mosunetuzumab, a first-in-class CD20xCD3 bispecific antibody, as a treatment for patients with follicular lymphoma (FL) in the EU. The European Commission has approved mosunetuzumab under the Lunsumio trade name for relapsed or refractory FL, the most common slow-growing form of non-Hodgkin lymphoma (NHL), after two or more prior systemic therapies.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Pharma Times
JUNE 8, 2022
The company received the Innovation Passport in the UK for zilebesiran, an investigational treatment of hypertension
pharmaphorum
JUNE 8, 2022
The UK medicines regulator has awarded Alnylam’s RNAi-based therapy zilebesiran for hypertension an ‘innovation passport ‘, a designation designed to speed up NHS access to promising new medicines. The passport means that LentiGlobin will be reviewed by the Medicines and Healthcare products Regulatory Agency (MHRA) via the new innovative licensing and access pathway (ILAP) introduced in 2020, which reduces the review time for a new medicine to 150 days.
Expert insights. Personalized for you.
131 
Let's personalize your content